{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:02:59Z","timestamp":1787241779046,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/ijo.ijo_339_17","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T23:34:16Z","timestamp":1510616056000},"page":"1127","source":"Crossref","is-referenced-by-count":11,"title":["The inhibitory effect of different concentrations of KH902 eye drops on corneal neovascularization induced by alkali burn"],"prefix":"10.4103","volume":"65","author":[{"given":"Zhenping","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.218043-1","first-page":"264","article-title":"Corneal angiogenic privilege: Angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)","author":"Azar","year":"2006","journal-title":"Trans Am Ophthalmol Soc"},{"key":"key-10.4103\/0301-4738.218043-2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcdb.2007.08.014","article-title":"Maintaining transparency: A review of the developmental physiology and pathophysiology of two avascular tissues","author":"Beebe","year":"2008","journal-title":"Semin Cell Dev Biol"},{"key":"key-10.4103\/0301-4738.218043-3","first-page":"961","article-title":"Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea","author":"Phillips","year":"1994","journal-title":"In Vivo"},{"key":"key-10.4103\/0301-4738.218043-4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1600-0420.2004.00312.x","article-title":"Vascular endothelium growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing","author":"Gan","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"key":"key-10.4103\/0301-4738.218043-5","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.218043-6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/08820530902801478","article-title":"Limbal stem cell deficiency and corneal neovascularization","author":"Lim","year":"2009","journal-title":"Semin Ophthalmol"},{"key":"key-10.4103\/0301-4738.218043-7","first-page":"649","article-title":"Vascular endothelial growth factor (VEGF) in normal human corneal epithelium: Detection and physiological importance","author":"van","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"key":"key-10.4103\/0301-4738.218043-8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","article-title":"Vascular endothelial growth factors and angiogenesis in eye disease","author":"Witmer","year":"2003","journal-title":"Prog Retin Eye Res"},{"key":"key-10.4103\/0301-4738.218043-9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.preteyeres.2008.11.005","article-title":"Therapeutic monoclonal antibodies in ophthalmology","author":"Rodrigues","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"key-10.4103\/0301-4738.218043-10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.4103\/0301-4738.218043-11","first-page":"18","article-title":"Requirement for vascular endothelial growth factor in wound-and inflammation-related corneal neovascularization","author":"Amano","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.218043-12","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.218043-13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00003226-200007000-00025","article-title":"Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor alpha, and transforming growth factor beta1 in human corneas with neovascularization","author":"Cursiefen","year":"2000","journal-title":"Cornea"},{"key":"key-10.4103\/0301-4738.218043-14","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","article-title":"VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment","author":"Cursiefen","year":"2004","journal-title":"J Clin Invest"},{"key":"key-10.4103\/0301-4738.218043-15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-0420.2006.00659.x","article-title":"Ocular angiogenesis: The role of growth factors","author":"Kvanta","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"key-10.4103\/0301-4738.218043-16","first-page":"211","article-title":"The comparison of efficacy of topical bevacizumab, etanercept and the combination of both drugs on experimental corneal neovascularization","author":"\u00d6zdemir","year":"2012","journal-title":"Turk Klin J Ophthalmol"},{"key":"key-10.4103\/0301-4738.218043-17","first-page":"209","article-title":"Comparison of the effects of subconjunctival and topical anti-VEGF therapy (bevacizumab) on experimental corneal neovascularization","author":"Ozdemir","year":"2014","journal-title":"Arq Bras Oftalmol"},{"key":"key-10.4103\/0301-4738.218043-18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ophtha.2010.08.008","article-title":"Aphase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration","author":"Zhang","year":"2011","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.218043-19","first-page":"1784","article-title":"Dynamics of corneal epithelial healing after an alkali burn.A statistical analysis","author":"Ormerod","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.218043-20","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","author":"D'Amato","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0301-4738.218043-21","doi-asserted-by":"crossref","first-page":"e15905","DOI":"10.1371\/journal.pone.0015905","article-title":"Anovel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis","author":"Bhattacharjee","year":"2011","journal-title":"PLoS One"},{"key":"key-10.4103\/0301-4738.218043-22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/02713683.2013.850098","article-title":"Anti-VEGF therapy (bevacizumab) for sulfur mustard-induced corneal neovascularization associated with delayed limbal stem cell deficiency in rabbits","author":"Kadar","year":"2014","journal-title":"Curr Eye Res"},{"key":"key-10.4103\/0301-4738.218043-23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: An anti-VEGF therapy review","author":"Chang","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.218043-24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00347-007-1512-2","article-title":"Inhibition of angiogenesis in the anterior chamber of the eye","author":"Bock","year":"2007","journal-title":"Ophthalmologe"},{"key":"key-10.4103\/0301-4738.218043-25","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.0506112103","article-title":"Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision","author":"Cursiefen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0301-4738.218043-26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s004170050118","article-title":"Effect of 0.1% dexamethasone on epithelial healing in experimental corneal alkali wounds: Morphological changes during the repair process","author":"Chung","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.218043-27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000111158","article-title":"Effects of acetylcysteine and dexamethasone on experimental corneal wounds in rabbits","author":"Sarchahi","year":"2008","journal-title":"Ophthalmic Res"},{"key":"key-10.4103\/0301-4738.218043-28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/02713680802245772","article-title":"Inhibitory effect of oral doxycycline on neovascularization in a rat corneal alkali burn model of angiogenesis","author":"Dan","year":"2008","journal-title":"Curr Eye Res"},{"key":"key-10.4103\/0301-4738.218043-29","first-page":"2148","article-title":"Fine needle diathermy occlusion of corneal vessels","author":"Pillai","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.218043-30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00003226-200307000-00018","article-title":"Photodynamic therapy of corneal neovascularization with verteporfin","author":"Fossarello","year":"2003","journal-title":"Cornea"},{"key":"key-10.4103\/0301-4738.218043-31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/ICO.0b013e318160d019","article-title":"Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs","author":"Hurmeric","year":"2008","journal-title":"Cornea"},{"key":"key-10.4103\/0301-4738.218043-32","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/archopht.125.6.834","article-title":"Topical bevacizumab therapy for corneal neovascularization","author":"DeStafeno","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.218043-33","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nrc909","article-title":"VEGF and the quest for tumour angiogenesis factors","author":"Ferrara","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key-10.4103\/0301-4738.218043-34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajo.2006.03.058","article-title":"Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model","author":"Bakri","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.218043-35","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s00417-013-2392-6","article-title":"Anti-angiogenic effect of KH902 on retinal neovascularization","author":"Wang","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0301-4738.218043-36","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/IAE.0000000000000900","article-title":"Intravitreal conbercept (KH902) for surgical treatment of severe proliferative diabetic retinopathy","author":"Su","year":"2016","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.218043-37","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ophtha.2014.03.026","article-title":"Safety and efficacy of conbercept in neovascular age-related macular degeneration: Results from a 12-month randomized phase 2 study: AURORA study","author":"Li","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.218043-38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000353437","article-title":"KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization","author":"Zhou","year":"2013","journal-title":"Ophthalmic Res"},{"key":"key-10.4103\/0301-4738.218043-39","first-page":"419","article-title":"Effect of KH902 in inhibiting suture induced corneal neovascularization","author":"Wang","year":"2014","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"key-10.4103\/0301-4738.218043-40","first-page":"1112","article-title":"Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea","author":"Edelman","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.218043-41","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1167\/iovs.08-2805","article-title":"Bevacizumab application delays epithelial healing in rabbit cornea","author":"Kim","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:37:27Z","timestamp":1786649847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_339_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017]]}},"alternative-id":["218043"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_339_17","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}